Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1010

1.

Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy.

Watanabe K, Kosaka T, Aimono E, Hongo H, Mikami S, Nishihara H, Oya M.

Clin Genitourin Cancer. 2019 Jun 13. pii: S1558-7673(19)30198-3. doi: 10.1016/j.clgc.2019.06.005. [Epub ahead of print] No abstract available.

PMID:
31296452
2.

MIG1 as a positive regulator for the histidine biosynthesis pathway and as a global regulator in thermotolerant yeast Kluyveromyces marxianus.

Nurcholis M, Murata M, Limtong S, Kosaka T, Yamada M.

Sci Rep. 2019 Jul 9;9(1):9926. doi: 10.1038/s41598-019-46411-5.

PMID:
31289320
Free Article
3.

TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells.

Niwa N, Tanaka N, Hongo H, Miyazaki Y, Takamatsu K, Mizuno R, Kikuchi E, Mikami S, Kosaka T, Oya M.

Lab Invest. 2019 Jul 1. doi: 10.1038/s41374-019-0285-y. [Epub ahead of print]

PMID:
31263157
4.

The neutrophil/lymphocyte ratio as a predictor of peritoneal metastasis during staging laparoscopy for advanced gastric cancer: a retrospective cohort analysis.

Nakamura N, Kinami S, Fujii Y, Miura S, Fujita J, Kaida D, Tomita Y, Miyata T, Fujita H, Ueda N, Iida Y, Kosaka T.

World J Surg Oncol. 2019 Jun 25;17(1):108. doi: 10.1186/s12957-019-1651-3.

5.

Correction: Capacity for survival in global warming: Adaptation of mesophiles to the temperature upper limit.

Kosaka T, Nakajima Y, Ishii A, Yamashita M, Yoshida S, Murata M, Kato K, Shiromaru Y, Kato S, Kanesaki Y, Yoshikawa H, Matsutani M, Thanonkeo P, Yamada M.

PLoS One. 2019 Jun 20;14(6):e0218985. doi: 10.1371/journal.pone.0218985. eCollection 2019.

6.

An Aggregation-defective Mutant of Methanothermobacter sp. CaT2 Reveals Unique Protein-dependent Aggregation.

Sumikawa K, Kosaka T, Mayahara N, Matsutani M, Udo K, Yamada M.

Microbes Environ. 2019 Jun 13. doi: 10.1264/jsme2.ME19014. [Epub ahead of print]

8.

Essential human resources for antimicrobial stewardship teams in Japan: Estimates from a nationwide survey conducted by the Japanese Society of Chemotherapy.

Maeda M, Muraki Y, Kosaka T, Yamada T, Aoki Y, Kaku M, Seki M, Tanabe Y, Fujita N, Niki Y, Morita K, Yanagihara K, Yoshida K, Kawaguchi T.

J Infect Chemother. 2019 Jun 7. pii: S1341-321X(19)30144-8. doi: 10.1016/j.jiac.2019.05.012. [Epub ahead of print]

PMID:
31182329
9.

Will minimally invasive sleeve resection become the future trend for treatment of advanced lung cancer?

Kosaka T, Shimizu K, Nakazawa S, Obayashi K, Ohtaki Y, Kawatani N, Ibe T, Yajima T, Mogi A, Shirabe K.

J Thorac Dis. 2019 Apr;11(4):1085-1087. doi: 10.21037/jtd.2019.02.95. No abstract available.

10.

Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers.

Aikawa A, Fujita H, Kosaka T, Minato H, Kiyokawa E.

Cancer Sci. 2019 Jun 7. doi: 10.1111/cas.14093. [Epub ahead of print]

11.

Impact of inappropriate empiric antimicrobial therapy on mortality in pediatric patients with bloodstream infection: a retrospective observational study.

Kyo M, Ohshimo S, Kosaka T, Fujita N, Shime N.

J Chemother. 2019 May 30:1-6. doi: 10.1080/1120009X.2019.1623362. [Epub ahead of print]

PMID:
31145044
12.

IVC angioplasty using an autologous vascular graft for IVC stenosis due to metallic stent in a pediatric liver transplant.

Kosaka T, Eguchi S, Hidaka M, Adachi T, Yoshino K, Kanetaka K, Takatsuki M, Ito S.

Pediatr Transplant. 2019 May 24:e13475. doi: 10.1111/petr.13475. [Epub ahead of print]

PMID:
31124585
13.

Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients.

Takamatsu K, Mizuno R, Tanaka N, Takeda T, Morita S, Matsumoto K, Kosaka T, Shinojima T, Kikuchi E, Asanuma H, Oyama M, Mikami S, Oya M.

Int J Clin Oncol. 2019 May 7. doi: 10.1007/s10147-019-01459-1. [Epub ahead of print]

PMID:
31065836
14.

Capacity for survival in global warming: Adaptation of mesophiles to the temperature upper limit.

Kosaka T, Nakajima Y, Ishii A, Yamashita M, Yoshida S, Murata M, Kato K, Shiromaru Y, Kato S, Kanasaki Y, Yoshikawa H, Matsutani M, Thanonkeo P, Yamada M.

PLoS One. 2019 May 7;14(5):e0215614. doi: 10.1371/journal.pone.0215614. eCollection 2019. Erratum in: PLoS One. 2019 Jun 20;14(6):e0218985.

15.

A case of early myoclonic encephalopathy with intractable seizures successfully treated with high-dose phenobarbital.

Kosaka T, Ohta G, Kometani H, Kawatani M, Ohshima Y.

Brain Dev. 2019 Apr 23. pii: S0387-7604(18)30606-5. doi: 10.1016/j.braindev.2019.04.007. [Epub ahead of print]

PMID:
31027651
16.

Precision surgical approach with lymph-node dissection in early gastric cancer.

Kinami S, Nakamura N, Tomita Y, Miyata T, Fujita H, Ueda N, Kosaka T.

World J Gastroenterol. 2019 Apr 14;25(14):1640-1652. doi: 10.3748/wjg.v25.i14.1640. Review.

17.

A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases.

Nakamura N, Kinami S, Fujii Y, Miura S, Fujita J, Kaida D, Tomita Y, Miyata T, Fujita H, Ueda N, Kosaka T.

Clin Case Rep. 2019 Feb 26;7(4):714-718. doi: 10.1002/ccr3.2056. eCollection 2019 Apr.

18.

The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy.

Takamatsu K, Matsumoto K, Shojo K, Tanaka N, Takeda T, Morita S, Kosaka T, Mizuno R, Shinojima T, Kikuchi E, Asanuma H, Oya M.

Urol Oncol. 2019 Apr 6. pii: S1078-1439(19)30105-X. doi: 10.1016/j.urolonc.2019.03.012. [Epub ahead of print]

PMID:
30967332
19.

Medial-basal segment (S7)-sparing right basal segmentectomy.

Yajima T, Shimizu K, Mogi A, Kosaka T, Nakazawa S, Shirabe K.

Gen Thorac Cardiovasc Surg. 2019 Apr 1. doi: 10.1007/s11748-019-01116-4. [Epub ahead of print]

PMID:
30937818
20.

Factors Influencing the Changes in Masticatory Performance: The Suita Study.

Kosaka T, Kida M, Kikui M, Hashimoto S, Fujii K, Yamamoto M, Nokubi T, Maeda Y, Hasegawa Y, Kokubo Y, Watanabe M, Higashiyama A, Miyamoto Y, Ono T.

JDR Clin Trans Res. 2018 Oct;3(4):405-412. doi: 10.1177/2380084418785863. Epub 2018 Jun 27.

PMID:
30931790
21.

Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma.

Iijima M, Yokobori T, Mogi A, Shimizu K, Yajima T, Kosaka T, Ohtaki Y, Obayashi K, Nakazawa S, Gombodorj N, Tsukagoshi M, Shirabe K, Kuwano H.

Ann Surg Oncol. 2019 Jun;26(6):1744-1750. doi: 10.1245/s10434-019-07268-0. Epub 2019 Mar 28.

PMID:
30924018
22.

Flagellum-mediated motility in Pelotomaculum thermopropionicum SI.

Kosaka T, Goda M, Inoue M, Yakushi T, Yamada M.

Biosci Biotechnol Biochem. 2019 Jul;83(7):1362-1371. doi: 10.1080/09168451.2019.1597618. Epub 2019 Mar 28.

PMID:
30919743
23.

Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer.

Kosaka T, Akiyama H, Miyamoto H, Sato S, Tanaka Y, Sato K, Kunisaki C, Endo I.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1047-1055. doi: 10.1007/s00280-019-03813-6. Epub 2019 Mar 25.

PMID:
30911769
24.

Tumor Volume Index as a Prognostic Factor in Patients after Curative Esophageal Cancer Resection.

Miyamoto H, Kunisaki C, Sato S, Tanaka Y, Sato K, Kosaka T, Yukawa N, Akiyama H, Saigusa Y, Endo I.

Ann Surg Oncol. 2019 Jun;26(6):1909-1915. doi: 10.1245/s10434-019-07308-9. Epub 2019 Mar 19.

PMID:
30891629
25.

Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.

Uemura H, Uemura H, Nagamori S, Wakumoto Y, Kimura G, Kikukawa H, Yokomizo A, Mizokami A, Kosaka T, Masumori N, Kawasaki Y, Yonese J, Nasu Y, Fukasawa S, Sugiyama T, Kinuya S, Hosono M, Yamaguchi I, Akagawa T, Matsubara N.

Int J Clin Oncol. 2019 May;24(5):557-566. doi: 10.1007/s10147-018-01389-4. Epub 2019 Mar 14.

26.

Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas.

Ohtaki Y, Shimizu K, Kawabata-Iwakawa R, Gombodorj N, Altan B, Rokudai S, Yamane A, Kaira K, Yokobori T, Nagashima T, Obayashi K, Nakazawa S, Iijima M, Kosaka T, Yajima T, Mogi A, Kuwano H, Shirabe K, Nishiyama M.

Oncotarget. 2019 Feb 12;10(13):1306-1319. doi: 10.18632/oncotarget.26657. eCollection 2019 Feb 12.

27.

Tooth loss leads to reduced nutrient intake in middle-aged and older Japanese individuals.

Kosaka T, Kida M.

Environ Health Prev Med. 2019 Mar 5;24(1):15. doi: 10.1186/s12199-019-0770-3.

28.

Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration.

Shigeta K, Kosaka T, Hongo H, Yanai Y, Matsumoto K, Morita S, Mizuno R, Shinojima T, Kikuchi E, Oya M.

Int J Clin Oncol. 2019 May;24(5):554-556. doi: 10.1007/s10147-019-01395-0.

PMID:
30826960
29.

Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer.

Matsumoto K, Akita H, Narita K, Hashiguchi A, Takamatsu K, Takeda T, Kosaka T, Mizuno R, Kikuchi E, Oya M, Jinzaki M.

Prostate Cancer Prostatic Dis. 2019 Feb 27. doi: 10.1038/s41391-019-0136-3. [Epub ahead of print]

PMID:
30814680
30.

Sulfasalazine could modulate the CD44v9-xCT system and enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer.

Ogihara K, Kikuchi E, Okazaki S, Hagiwara M, Takeda T, Matsumoto K, Kosaka T, Mikami S, Saya H, Oya M.

Cancer Sci. 2019 Apr;110(4):1431-1441. doi: 10.1111/cas.13960. Epub 2019 Mar 1.

31.

Fas/FasL signaling is critical for the survival of exhausted antigen-specific CD8+ T cells during tumor immune response.

Yajima T, Hoshino K, Muranushi R, Mogi A, Onozato R, Yamaki E, Kosaka T, Tanaka S, Shirabe K, Yoshikai Y, Kuwano H.

Mol Immunol. 2019 Mar;107:97-105. doi: 10.1016/j.molimm.2019.01.014. Epub 2019 Jan 30.

PMID:
30711908
32.

[A Case of Sigmoid Cancer with Six Asynchronistic Metastases to Multiple Organs That Were Resected through Four Surgeries].

Ueda N, Fujii Y, Miura S, Fujita J, Tomita Y, Fujita H, Kinami S, Kosaka T, Usuda K, Uramoto H.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2081-2083. Japanese.

PMID:
30692291
33.

Sealed endoscopic full-thickness resection for gastric cancer: a pilot study in an ex vivo and in vivo porcine model.

Kitakata H, Itoh T, Kinami S, Kawaura K, Hamada K, Azukisawa S, Kobayashi R, Kamai J, Kosaka T.

Endosc Int Open. 2019 Jan;7(1):E36-E42. doi: 10.1055/a-0777-1954. Epub 2019 Jan 3.

34.

Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration.

Shigeta K, Kosaka T, Hongo H, Yanai Y, Matsumoto K, Morita S, Mizuno R, Shinojima T, Kikuchi E, Oya M.

Int J Clin Oncol. 2019 May;24(5):546-553. doi: 10.1007/s10147-018-01388-5. Epub 2019 Jan 2. Erratum in: Int J Clin Oncol. 2019 Mar 2;:.

PMID:
30604159
35.

Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions.

Sugiura Y, Takeo E, Shimma S, Yokota M, Higashi T, Seki T, Mizuno Y, Oya M, Kosaka T, Omura M, Nishikawa T, Suematsu M, Nishimoto K.

Hypertension. 2018 Dec;72(6):1345-1354. doi: 10.1161/HYPERTENSIONAHA.118.11243.

PMID:
30571232
36.

Risk stratification of castration-resistant prostate cancer patients treated with cabazitaxel.

Kosaka T, Hongo H, Mizuno R, Oya M.

Mol Clin Oncol. 2018 Dec;9(6):683-688. doi: 10.3892/mco.2018.1724. Epub 2018 Sep 19.

37.

Evaluation of prostate-specific antigen density in the diagnosis of prostate cancer combined with magnetic resonance imaging before biopsy in men aged 70 years and older with elevated PSA.

Yanai Y, Kosaka T, Hongo H, Matsumoto K, Shinojima T, Kikuchi E, Miyajima A, Mizuno R, Mikami S, Jinzaki M, Oya M.

Mol Clin Oncol. 2018 Dec;9(6):656-660. doi: 10.3892/mco.2018.1725. Epub 2018 Sep 19.

38.

Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study.

Koga T, Kobayashi Y, Tomizawa K, Suda K, Kosaka T, Sesumi Y, Fujino T, Nishino M, Ohara S, Chiba M, Shimoji M, Takemoto T, Suzuki M, Jänne PA, Mitsudomi T.

Lung Cancer. 2018 Dec;126:72-79. doi: 10.1016/j.lungcan.2018.10.019. Epub 2018 Oct 17.

PMID:
30527195
39.

A Phase II Study of Tri-weekly Low-dose Nab-paclitaxel Chemotherapy for Patients with Advanced Gastric Cancer.

Sato S, Kunisaki C, Tanaka Y, Sato K, Miyamoto H, Yukawa N, Fujii Y, Kimura J, Takagawa R, Takahashi M, Kosaka T, Akiyama H, Saigusa Y, Taguri M, Yamanaka T, Endo I.

Anticancer Res. 2018 Dec;38(12):6911-6917. doi: 10.21873/anticanres.13068.

PMID:
30504409
40.

Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia.

Takamatsu K, Nakane S, Suzuki S, Kosaka T, Fukushima S, Kimura T, Miyashita A, Mukaino A, Yamakawa S, Watanabe K, Jinnin M, Komohara Y, Ihn H, Ando Y.

Ann Clin Transl Neurol. 2018 Sep 23;5(11):1421-1427. doi: 10.1002/acn3.654. eCollection 2018 Nov.

41.

Clinical outcome of high dose rate brachytherapy with external beam radiotherapy for high-risk prostate cancer: a single institutional retrospective study.

Shirotake S, Makino S, Suzuki K, Araki R, Kosaka T, Nishimoto K, Oyama M, Kato S.

Jpn J Clin Oncol. 2019 Jan 1;49(1):87-91. doi: 10.1093/jjco/hyy174.

PMID:
30476164
42.

Hydrostatic Pressure on Toroidal Interaction and Propeller Chirality of Hexaarylbenzenes: Explicit Solvent Effects on Differential Volumes in Methylcyclohexane and Hexane.

Kosaka T, Iwai S, Fukuhara G, Imai Y, Mori T.

Chemistry. 2019 Feb 6;25(8):2011-2018. doi: 10.1002/chem.201804688. Epub 2019 Jan 9.

PMID:
30474891
43.

The first nationwide survey of antimicrobial stewardship programs conducted by the Japanese Society of Chemotherapy.

Maeda M, Muraki Y, Kosaka T, Yamada T, Aoki Y, Kaku M, Kawaguchi T, Seki M, Tanabe Y, Fujita N, Morita K, Yanagihara K, Yoshida K, Niki Y.

J Infect Chemother. 2019 Feb;25(2):83-88. doi: 10.1016/j.jiac.2018.11.001. Epub 2018 Nov 22. No abstract available.

44.

The impact of histology and ground-glass opacity component on volume doubling time in primary lung cancer.

Obayashi K, Shimizu K, Nakazawa S, Nagashima T, Yajima T, Kosaka T, Atsumi J, Kawatani N, Yazawa T, Kaira K, Mogi A, Kuwano H.

J Thorac Dis. 2018 Sep;10(9):5428-5434. doi: 10.21037/jtd.2018.08.118.

45.

Prognostic significance of PD-L1 expression and tumor infiltrating lymphocytes in large cell neuroendocrine carcinoma of lung.

Ohtaki Y, Kaira K, Atsumi J, Nagashima T, Kawashima O, Ibe T, Kamiyoshihara M, Onozato R, Fujita A, Yazawa T, Sugano M, Iijima M, Nakazawa S, Obayashi K, Kosaka T, Yajima T, Kuwano H, Shirabe K, Mogi A, Shimizu K.

Am J Transl Res. 2018 Oct 15;10(10):3243-3253. eCollection 2018.

46.

Functional analysis of Mig1 and Rag5 as expressional regulators in thermotolerant yeast Kluyveromyces marxianus.

Nurcholis M, Nitiyon S, Suprayogi, Rodrussamee N, Lertwattanasakul N, Limtong S, Kosaka T, Yamada M.

Appl Microbiol Biotechnol. 2019 Jan;103(1):395-410. doi: 10.1007/s00253-018-9462-y. Epub 2018 Nov 5.

PMID:
30397769
47.

Single-cell RNA-seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63.

Tanaka N, Katayama S, Reddy A, Nishimura K, Niwa N, Hongo H, Ogihara K, Kosaka T, Mizuno R, Kikuchi E, Mikami S, Miyakawa A, Arenas E, Kere J, Oya M, Uhlén P.

Cancer Med. 2018 Dec;7(12):6193-6204. doi: 10.1002/cam4.1828. Epub 2018 Oct 26.

48.

No significant impact of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancer.

Kosaka T, Hongo H, Watanabe K, Mizuno R, Kikuchi E, Oya M.

Cancer Chemother Pharmacol. 2018 Dec;82(6):1061-1066. doi: 10.1007/s00280-018-3698-1. Epub 2018 Oct 3.

49.

Cerebrotendinous xanthomatosis presenting with extensive cerebral cortex symptoms: A case report.

Mukaino A, Tsuda M, Yamashita S, Kosaka T, Wada K, Ando Y.

Clin Neurol Neurosurg. 2018 Nov;174:217-219. doi: 10.1016/j.clineuro.2018.09.028. Epub 2018 Sep 20. No abstract available.

PMID:
30278298
50.

A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer.

Tanaka Y, Kunisaki C, Izumisawa Y, Makino H, Kimura J, Sato S, Miyamoto H, Kosaka T, Ono HA, Takahashi M, Sato K, Akiyama H, Endo I.

Anticancer Res. 2018 Oct;38(10):6015-6021. doi: 10.21873/anticanres.12951.

PMID:
30275234

Supplemental Content

Loading ...
Support Center